The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2021 | Predicting drug resistance using single cell RNA sequencing in myeloma
Hareth Nahi, MD, PhD, of the Karolinska Institutet, Stockholm, Sweden, outlines how single-cell RNA sequencing can be used to predict drug resistance in patients with multiple myeloma. Dr Nahi reports that single-cell RNA sequencing is helping to identify cellular pathways and mechanisms of resistance, therefore contributing to improving our understanding of the biology underlying multiple myeloma. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.
